| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/01/2007 | CA2620267A1 Genes involved in asymmetric cell division |
| 03/01/2007 | CA2620082A1 Genemap of the human genes associated with crohn's disease |
| 03/01/2007 | CA2619833A1 Use of crispr associated genes (cas) |
| 03/01/2007 | CA2619761A1 Detecting pathogens in companion animals |
| 03/01/2007 | CA2619478A1 Use of holographic sensor |
| 03/01/2007 | CA2616504A1 Microfluidic methods for diagnostics and cellular analysis |
| 03/01/2007 | CA2545613A1 Methods for the amplification and quantitation of nucleic acids |
| 02/28/2007 | EP1757938A1 Method of examining interstitial cystitis |
| 02/28/2007 | EP1757935A1 Gene detection method and gene detection apparatus |
| 02/28/2007 | EP1757932A2 Ion channel assay methods |
| 02/28/2007 | EP1757705A2 Intraoperative lymph node assay |
| 02/28/2007 | EP1757704A2 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 02/28/2007 | EP1757698A1 Polypeptides having dna polymerase activity |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757693A2 Nucleic acids showing difference in expression between hepatoblastoma and normal liver |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757691A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103 |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757688A1 Method of disulfide crosslink forming type in vitro protein synthesis |
| 02/28/2007 | EP1757683A1 Method of making a mutated type IIT endonuclease which has nicking activity |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757306A1 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 02/28/2007 | EP1757302A1 Adiponectin expression inducer and utilization of the same |
| 02/28/2007 | EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 02/28/2007 | EP1756580A1 Reagents, devices and methods for proteomic analysis with applications including diagnostics and vaccines |
| 02/28/2007 | EP1756577A2 Methods and compositions for the detection of cervical disease |
| 02/28/2007 | EP1756576A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 10 (dpp10) |
| 02/28/2007 | EP1756573A1 Adsorption agent for nucleic acids containing acid-activated phyllosilicate |
| 02/28/2007 | EP1756566A2 Biomarkers for ovarian cancer |
| 02/28/2007 | EP1756557A1 Electrochemical cell and method of making an electrochemical cell |
| 02/28/2007 | EP1756319A2 Association of breast cancer dna methylation profiles with hormone receptor status and response to tamoxifen |
| 02/28/2007 | EP1756318A2 Aptamer-toxin molecules and method for using same |
| 02/28/2007 | EP1756317A2 Methods for identifying risk of osteoarthritis and treatments thereof |
| 02/28/2007 | EP1756316A2 Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof |
| 02/28/2007 | EP1756315A1 Human obesity susceptibility gene encoding a taste receptor and uses thereof |
| 02/28/2007 | EP1756314A1 Biomarkers for the prediction of responsiveness to clozapine treatment |
| 02/28/2007 | EP1756313A2 Sequence-specific detection of methylation in biomolecules |
| 02/28/2007 | EP1756312A1 Genotyping of multiple loci with pcr for different loci amplification at different temperatures |
| 02/28/2007 | EP1756311A2 Silencing of tumor-suppressive genes by cpg-methylation in prostate cancer |
| 02/28/2007 | EP1756310A2 Polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
| 02/28/2007 | EP1756309A2 Methods for predicting and monitoring response to cancer therapy |
| 02/28/2007 | EP1756308A1 Compositions and methods for breast cancer prognosis |
| 02/28/2007 | EP1756307A1 Use of mass labelled probes to detect target nucleic acids using mass spectrometry |
| 02/28/2007 | EP1756306A2 Identification and characterization of a subset of glioblastomas sensitive to treatment with imatinib |
| 02/28/2007 | EP1756305A1 Aptamers selected from live tumor cells and the use thereof |
| 02/28/2007 | EP1756304A2 Rnai-based target identification and validation |
| 02/28/2007 | EP1756303A2 Diagnostic tool for diagnosing benign versus malignant thyroid lesions |
| 02/28/2007 | EP1756302A1 A method for selectively detecting subsets of nucleic acid molecules |
| 02/28/2007 | EP1756301A1 A method for monitoring the progress of cancer |
| 02/28/2007 | EP1756300A1 Nucleic acid sequencing |
| 02/28/2007 | EP1756299A1 Nucleic acid sequencing |
| 02/28/2007 | EP1756298A2 Diagnosis and prognosis of wound infection by measurement of a phospholipase a2 in wound fluid |
| 02/28/2007 | EP1756297A2 High throughput reactive oxygen species-based cytochrome p450 inhibition assay |
| 02/28/2007 | EP1756296A1 Biological indicator |
| 02/28/2007 | EP1756295A1 Biological soil detector and method of using same |
| 02/28/2007 | EP1756294A1 Residual enzyme assay |
| 02/28/2007 | EP1756291A2 Enzymatic decarboxylation of 2-keto-l-gulonic acid to produce xylose |
| 02/28/2007 | EP1756277A2 Quasirandom structure and function guided synthesis methods |
| 02/28/2007 | EP1756274A1 Lipolytic enzyme assay |
| 02/28/2007 | EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 02/28/2007 | EP1756159A1 C1q family member proteins with altered immunogenicity |
| 02/28/2007 | EP1756137A2 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 02/28/2007 | EP1756136A2 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 02/28/2007 | EP1756129A1 Novel dna threading intercalators |
| 02/28/2007 | EP1755785A1 Single molecule amplification and detection of dna length |
| 02/28/2007 | EP1755667A2 Stable peptide mimetic of hiv gp41 fusion intermediate |
| 02/28/2007 | EP1755539A2 Flavivirus vaccines |
| 02/28/2007 | EP1713930A4 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 02/28/2007 | EP1633381A4 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 02/28/2007 | EP1579013A4 Method for profiling and identifying persons by using data samples |
| 02/28/2007 | EP1471355B1 Method of fixing biomolecule to carrier |
| 02/28/2007 | EP1466015A4 Bioconjugate-nanoparticle probes |
| 02/28/2007 | EP1410055B1 Method and device for analysing the intracellular chemical state of living cells by nuclear magnetic resonance |
| 02/28/2007 | EP1364050B1 Method for the diagnosis of schizophrenia |
| 02/28/2007 | EP1313876B8 Process for detecting acetylase or deacetylase activity in an immunoassay |
| 02/28/2007 | EP1254240B1 Hybrid protease with reduced antigenicity and its use |
| 02/28/2007 | EP1250424B1 Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules |
| 02/28/2007 | EP1248848B1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 02/28/2007 | EP1224310B1 Recombinant adenoviruses preparation and adenovirus banks |
| 02/28/2007 | EP1175510B1 Mismatch repair detection |
| 02/28/2007 | EP1067879B1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation |
| 02/28/2007 | EP1055005B1 Quantitative determination of nucleic acid amplification products |
| 02/28/2007 | EP1053347B1 Peptide detection method |
| 02/28/2007 | EP1017853B1 Normalized nucleic acid libraries and methods of production thereof |
| 02/28/2007 | EP0945506B1 Proteine avec une activite de suppression du vieillissement |
| 02/28/2007 | EP0909323B1 Helicobacter pylori bacterioferritin |
| 02/28/2007 | EP0857211B1 Intensive homologous promoter obtained from hamsters |
| 02/28/2007 | EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/28/2007 | CN1922490A Identification of cancer protein biomarkers using proteomic techniques |
| 02/28/2007 | CN1922489A Staphylococcus detection |
| 02/28/2007 | CN1922478A Microfluidic test device |
| 02/28/2007 | CN1922332A Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 02/28/2007 | CN1922331A Direct nucleic acid detection in bodily fluids |
| 02/28/2007 | CN1922330A Rnai agents for anti-sars coronavirus therapy |
| 02/28/2007 | CN1922324A Bacterial virulence factors and uses thereof |